121.68
+5.08
+(4.36%)
At close: October 2 at 9:40:18 AM GMT-3
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 8 | 7 | 12 | 12 |
Avg. Estimate | 88.23B | 84.63B | 354.47B | 339.5B |
Low Estimate | 78.46B | 76.91B | 341.21B | 309.74B |
High Estimate | 106.59B | 96.58B | 369.68B | 401.86B |
Year Ago Sales | 84.34B | 83.08B | 344.58B | 354.47B |
Sales Growth (year/est) | 4.61% | 1.86% | 2.87% | -4.22% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
XOM.SN | -- | -- | -- | -- |
S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
Maintains | Truist Securities: Hold to Hold | 1/13/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 12/19/2024 |
Maintains | JP Morgan: Overweight to Overweight | 12/16/2024 |
Maintains | Mizuho: Neutral to Neutral | 12/16/2024 |
Maintains | UBS: Buy to Buy | 12/12/2024 |
Reiterates | RBC Capital: Sector Perform to Sector Perform | 12/12/2024 |